Last $22.55 USD
Change Today +0.16 / 0.71%
Volume 490.9K
MDAS On Other Exchanges
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

medassets inc (MDAS) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/25/13 - $26.58
52 Week Low
07/15/13 - $18.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDASSETS INC (MDAS)

medassets inc (MDAS) Related Bloomberg News

View More Bloomberg News

medassets inc (MDAS) Related Businessweek News

No Related Businessweek News Found

medassets inc (MDAS) Details

MedAssets, Inc., a financial and performance improvement company, provides technology-enabled products and services for hospitals, health systems, and other ancillary healthcare providers in the United States. It operates in two segments, Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment provides a suite of cost management services, supply chain analytics, and data capabilities; strategic sourcing and group purchasing services; medical device and clinical resource consulting services; lean performance improvement services; workforce management; and supply chain outsourcing and procurement services. This segment is also involved in the provision of business intelligence and decision support tool services. The RCM segment offers a suite of software as a service or Web-based software and technology-enabled services, which address various revenue cycle processes comprising patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing, denials management and reimbursement integrity, payer contract management, extended business office revenue recovery, accounts receivable services, and outsourcing services. As of December 31, 2013, the company served approximately 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. MedAssets, Inc. was incorporated in 1999 and is headquartered in Alpharetta, Georgia.

3,200 Employees
Last Reported Date: 03/3/14
Founded in 1999

medassets inc (MDAS) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $1.4M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $660.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $810.1K
President of Spend and Clinical Resource Mana...
Total Annual Compensation: $518.9K
Chief Customer Officer, Senior Executive Vice...
Total Annual Compensation: $727.2K
Compensation as of Fiscal Year 2013.

medassets inc (MDAS) Key Developments

Centegra Health System Expands Relationship with MedAssets to Mitigate Risk and Optimize Net Revenue Performance

MedAssets announced that Centegra Health System expanded its relationship with the company to include its comprehensive portfolio of revenue performance improvement solutions. The new agreement will support Centegra's initiatives to become a value-based organization in preparation for risk-based reimbursement models. Plans call for the use of multiple MedAssets solutions including, Revenue Cycle Performance, Recovery and Collections, Patient Access, Claims & Billing, and Contract & Episode Management solutions to support the regional health provider overcome increased margin pressures, assume greater risk and manage more complexity in coding and payor contracting.

MedAssets, Inc. Introduces First Module of Revenue Cycle Analytics Product Suite

MedAssets announced the introduction of Contract Analytics, the first module of Revenue Cycle Analytics, a robust analytical discovery product suite designed to improve revenue cycle efficiency and visibility into reimbursement performance. Contract Analytics provides dynamic access to critical revenue cycle data to enable executives and front-line associates alike to gain timely insights into reimbursement trends, recognize issues and variances in payor performance, and identify impacts to operational goals. As a result, health system leaders are empowered to take swift action with fact-based decisions. Tool features include: Data aggregation from multiple sources including data from MedAssets Contract Management product and the health system's patient accounting system(s). Interactive key performance indicator dashboards. Each dashboard provides analytical discovery through summary views and drill down capabilities to line item level. Standard and ad hoc reporting capabilities that leverage hundreds of revenue cycle data elements to enable root cause analysis in minutes. Accessibility via iPad application enabling on-the-go performance monitoring and decisions.

MedAssets Unveils Next Generation Decision Support Costing and Contracting System

MedAssets unveiled the upgraded version of Decision Support Costing and Contracting, a business intelligence tool that combines clinical, operational and financial system data from across care settings. With this MedAssets platform, health systems can drive more informed financial, operational, clinical and strategic planning decisions on a daily basis. MedAssets is showcasing the new version of Decision Support Costing and Contracting at the 2014 HFMA National Institute, June 22-25 in Las Vegas (Booth #412). The new version of Decision Support Costing and Contracting is in response to a convergence of economic, regulatory and social factors creating increased business need for providers to better measure costs over the full cycle of patient care. Featuring a new technology platform, an enhanced user interface and a flexible analytics suite, Decision Support Costing and Contracting synthesizes information from the hospital's patient accounting system, enterprise resource planning and other health system data from both inpatient and outpatient settings. The intuitive, Web-based tool is backed by MedAssets extensive healthcare data expertise and superior implementation and planning services designed to support transformational performance improvement. The new version of Decision Support Costing and Contracting enables providers to synthesize complex sets of data to measure total cost of care at the patient level in support of episodic contracting methodologies and population health management. The business intelligence embedded in the new version of Decision Support Costing and Contracting provides users with the ability to easily customize and define views of the decision support data based on their specific requirements and needs. Combined with the MedAssets Decision Budgeting and Decision Analytics modules, which were released in 2013, this new suite of healthcare tools provides clients with a comprehensive solution for cost accounting and financial decision support and analysis.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDAS:US $22.55 USD +0.16

MDAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accretive Health Inc $8.75 USD +0.60
Huron Consulting Group Inc $66.30 USD -0.50
Navigant Consulting Inc $16.81 USD -0.15
Advisory Board Co/The $50.66 USD -0.19
WebMD Health Corp $51.33 USD -0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation MDAS Industry Range
Price/Earnings 50.6x
Price/Sales 2.0x
Price/Book 2.8x
Price/Cash Flow 10.5x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDASSETS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at